It was suggested that PGE 1 confers protection against endometriosis by attenuating the secretion of TNF-, IFN- and interleukins (IL-2, IL-4 and IL-6), while PGE 2 induces cytokine release and thus endometriosis through its apoptotic and inflammatory functions [19, 46]
PRP delivers a concentrated burst of growth factors at the injection site, while BPC-157 sustains the angiogenic and healing environment that PRP initiates
Fatigue, mood instability, poor immunity, and nerve symptoms are not issues to ignore
Conclusions In patients with overweight or obesity and without T2DM, treatment with semaglutide 2.4 mg and tirzepatide was associated with 14.1% and 16.5% weight loss, respectively, after a 1-year follow-up period, indicating the effectiveness of these therapies in routine clinical practice in the US